Yu YY, Chen C, Kong FF, & Zhang W. (2014). Clinicopathological significance and potential drug target of RUNX3 in breast cancer. Dove Medical Press.
Chicago Style (17th ed.) CitationYu YY, Chen C, Kong FF, and Zhang W. Clinicopathological Significance and Potential Drug target of RUNX3 in Breast Cancer. Dove Medical Press, 2014.
MLA (9th ed.) CitationYu YY, et al. Clinicopathological Significance and Potential Drug target of RUNX3 in Breast Cancer. Dove Medical Press, 2014.
Warning: These citations may not always be 100% accurate.